CN111803552A - A Chinese medicinal composition for treating eye diseases - Google Patents
A Chinese medicinal composition for treating eye diseases Download PDFInfo
- Publication number
- CN111803552A CN111803552A CN202010702633.2A CN202010702633A CN111803552A CN 111803552 A CN111803552 A CN 111803552A CN 202010702633 A CN202010702633 A CN 202010702633A CN 111803552 A CN111803552 A CN 111803552A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- eye diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
Abstract
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating eye diseases. The traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 10-15 parts of ash bark; 10-15 parts of mirabilite; 15-20 parts of sarcandra; 5-10 parts of green boxes; 5-10 parts of green salt; 3-6 parts of dried orange peel; 1-5 parts of equisetum; 10-15 parts of coptis chinensis; grinding the traditional Chinese medicine composition to 100 meshes, and fully stirring and mixing the ground medicinal powder for later use; and (3) preparing the uniformly mixed traditional Chinese medicine composition into a traditional Chinese medicine plaster. The traditional Chinese medicine composition for treating eye diseases is used for treating eye diseases such as sudden fire eyes, red and swollen eyes, acute eruptive eye pricking pain, itching and lacrimation of eyes, hypermetropia, myopia, optic atrophy, conjunctivitis, corneal pain, corneal edema, nebula and nebula, pterygium, eye swelling and pain, clear and clear pain, cataract, muscae volitantes, eye turbidity, blurred vision and glaucoma.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating eye diseases.
Background
The eyes are important organs of the human body and one of the most frequently used organs of the human body, and along with the improvement of the life quality of people, the protection of the eyes is more and more emphasized. However, eye discomfort is also frequently caused by eye diseases such as sudden burning, red and swollen eyes, acute and painful eyes, itching and tearing eyes, hypermetropia, myopia, optic atrophy, conjunctivitis, corneal pain, corneal edema, nebula, pterygium, eye swelling and pain, clear and painful eyes, cataract, muscae volitantes, turbid eyes, blurred vision and glaucoma.
The existing medicines for treating ophthalmic diseases generally have the problems of slow effect and poor treatment effect.
Disclosure of Invention
Aiming at the defects in the prior art, the traditional Chinese medicine composition for treating eye diseases solves the technical problems, and provides a traditional Chinese medicine composition capable of effectively treating fulminant eyes, red and swollen eyes, acute stabbing pain, itching and lacrimation of eyes, hypermetropia, myopia, optic atrophy, conjunctivitis, corneal pain, corneal edema, nebula, pterygium, eye swelling and pain, clear pain, cataract, muscae volitantes, eye opacity, blurred vision and glaucoma eye diseases.
In order to achieve the purpose, the invention provides the following technical scheme:
a traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 10-15 parts of ash bark; 10-15 parts of mirabilite; 15-20 parts of sarcandra; 5-10 parts of green boxes; 5-10 parts of green salt; 3-6 parts of dried orange peel; 1-5 parts of equisetum; 10-15 parts of coptis chinensis.
A traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 10 parts of ash bark; 10 parts of mirabilite; 15 parts of sarcandra; 6 parts of a green box; 6 parts of green salt; 3 parts of dried orange peel; 5 parts of equisetum; 10 parts of coptis chinensis.
A traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 12 parts of ash bark; 13 parts of mirabilite; 18 parts of sarcandra; 7 parts of a green box; 7 parts of green salt; 5 parts of dried orange peel; 2 parts of equisetum; 13 parts of coptis chinensis.
A traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 15 parts of ash bark; 15 parts of mirabilite; 20 parts of sarcandra; 5 parts of a green box; 10 parts of green salt; 5 parts of dried orange peel; 4 parts of equisetum; 10-15 parts of coptis chinensis.
A traditional Chinese medicine composition for treating eye diseases comprises the following preparation steps:
step 1: grinding the traditional Chinese medicine composition to 100 meshes, and fully stirring and mixing the ground medicinal powder for later use;
step 2: and (3) preparing the uniformly mixed traditional Chinese medicine composition into a traditional Chinese medicine plaster.
A process for preparing a Chinese medicinal patch for treating eye diseases comprises the following steps: putting the Chinese medicinal composition into a medicine bag; the medicine bag is a non-woven fabric bag, and the length of the non-woven fabric bag is 15-25cm, and the width of the non-woven fabric bag is 4-6 cm.
Wherein the preparation method further comprises steaming the Chinese medicinal patch with water for 20-30min, and cooling to 40-42 deg.C.
Wherein, the traditional Chinese medicine composition is added with capsule auxiliary agents to prepare capsules.
The invention has the beneficial effects that: the traditional Chinese medicine composition for treating eye diseases is used for treating eye diseases such as sudden fire eyes, red and swollen eyes, acute eruptive eye pricking pain, itching and lacrimation eyes, hypermetropia, myopia, optic atrophy, conjunctivitis, corneal pain, corneal edema, nebula, pterygium, eye swelling and pain, clear and clear pain, cataract, muscae volitantes, eye turbidity, blurred vision and glaucoma. And can be used for treating trachoma, blepharitis, hordeolum, acute conjunctivitis, chronic conjunctivitis, allergic keratitis, suppurative keratitis, and corneal nebula. But also has curative effect on adjuvant therapy of cataract and prevention of eye fatigue, dryness, and eye pollution caused by smoke dust and sand.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
A traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 10-15 parts of ash bark; 10-15 parts of mirabilite; 15-20 parts of sarcandra; 5-10 parts of green boxes; 5-10 parts of green salt; 3-6 parts of dried orange peel; 1-5 parts of equisetum; 10-15 parts of coptis chinensis.
Example 1:
a traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 10 parts of ash bark; 10 parts of mirabilite; 15 parts of sarcandra; 6 parts of a green box; 6 parts of green salt; 3 parts of dried orange peel; 5 parts of equisetum; 10 parts of coptis chinensis.
Example 2:
a traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 12 parts of ash bark; 13 parts of mirabilite; 18 parts of sarcandra; 7 parts of a green box; 7 parts of green salt; 5 parts of dried orange peel; 2 parts of equisetum; 13 parts of coptis chinensis.
Example 3:
a traditional Chinese medicine composition for treating eye diseases comprises the following components in parts by weight: 15 parts of ash bark; 15 parts of mirabilite; 20 parts of sarcandra; 5 parts of a green box; 10 parts of green salt; 5 parts of dried orange peel; 4 parts of equisetum; 10-15 parts of coptis chinensis.
A traditional Chinese medicine composition for treating eye diseases comprises the following preparation steps:
step 1: grinding the traditional Chinese medicine composition to 100 meshes, and fully stirring and mixing the ground medicinal powder for later use;
step 2: and (3) preparing the uniformly mixed traditional Chinese medicine composition into a traditional Chinese medicine plaster.
A process for preparing a Chinese medicinal patch for treating eye diseases comprises the following steps: putting the Chinese medicinal composition into a medicine bag; the medicine bag is a non-woven fabric bag, and the length of the non-woven fabric bag is 20cm, and the width of the non-woven fabric bag is 5 cm.
Specifically, the preparation method further comprises the steps of steaming the traditional Chinese medicine application for 30min, and then cooling to 40 ℃.
Specifically, the traditional Chinese medicine composition is added with capsule auxiliary agents to prepare capsules.
The traditional Chinese medicine composition is suitable for people: glaucoma, cataract, vitreous opacity, muscae volitantes, dry eye, and tearing against wind, which are caused by the accumulation of toxins on the lens, often tearing, photophobia, and double images, and are particularly difficult! The 'plain questions, gold Kui Zhen Lun' is recorded: "human opens to the liver and opens into the eyes". Medical studies now show that: the eyes are caused by accumulation of toxins, and as long as the liver eye channel is opened, the disease root of the eye toxin is thoroughly solved, and the eyes are naturally clear and bright.
The accumulation of eye poison in the crystalline lens can cause the protein deformation and edema of the crystalline lens, change the crystalline lens from transparent to turbid and cause cataract. The accumulation of eye poison in vitreous body can cause vitreous body turbidity, and has mosquito-repelling disease. Should the toxins block the passage of aqueous humor circulation, an increase in intraocular pressure is produced, which can lead to glaucoma. The eye toxicity is generated on the fundus oculi, which can cause macular degeneration of the fundus oculi. Once the ocular toxicity damages the fundus nerves, the vision is gradually weakened, and even the vision is seriously blinded.
The usage and dosage are as follows: the eye is massaged for 30 minutes, and after the channels and collaterals of the eye are dredged, the eye is fumigated, so that the effect is better.
Typical cases are as follows:
wangzhi, female, 53 years old, and double-eye xerophthalmia, which is cured by medication for one month.
Zhangzhi, male, 66 years old, had cataract in both eyes, and was cured by medication for one month.
Summer-cured women, age 48, with vitreous opacity, were cured by a one-month treatment with medication.
The dosage is conventional dosage and application method.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (8)
1. A traditional Chinese medicine composition for treating eye diseases is characterized by comprising the following components in parts by weight: 10-15 parts of ash bark; 10-15 parts of mirabilite; 15-20 parts of sarcandra; 5-10 parts of green boxes; 5-10 parts of green salt; 3-6 parts of dried orange peel; 1-5 parts of equisetum; 10-15 parts of coptis chinensis.
2. The traditional Chinese medicine composition for treating eye diseases according to claim 1, which is characterized by comprising the following components in parts by weight: 10 parts of ash bark; 10 parts of mirabilite; 15 parts of sarcandra; 6 parts of a green box; 6 parts of green salt; 3 parts of dried orange peel; 5 parts of equisetum; 10 parts of coptis chinensis.
3. The traditional Chinese medicine composition for treating eye diseases according to claim 1, which is characterized by comprising the following components in parts by weight: 12 parts of ash bark; 13 parts of mirabilite; 18 parts of sarcandra; 7 parts of a green box; 7 parts of green salt; 5 parts of dried orange peel; 2 parts of equisetum; 13 parts of coptis chinensis.
4. The traditional Chinese medicine composition for treating eye diseases according to claim 1, which is characterized by comprising the following components in parts by weight: 15 parts of ash bark; 15 parts of mirabilite; 20 parts of sarcandra; 5 parts of a green box; 10 parts of green salt; 5 parts of dried orange peel; 4 parts of equisetum; 10-15 parts of coptis chinensis.
5. The traditional Chinese medicine composition for treating eye diseases according to claim 1, which is characterized by comprising the following preparation steps:
step 1: grinding the traditional Chinese medicine composition to 100-150 meshes, and fully stirring and mixing the ground medicinal powder for later use;
step 2: and (3) preparing the uniformly mixed traditional Chinese medicine composition into a traditional Chinese medicine plaster.
6. The Chinese medicinal composition for treating eye diseases according to claim 5, wherein the process of preparing the Chinese medicinal composition into the Chinese medicinal patch comprises the following steps: putting the Chinese medicinal composition into a medicine bag; the medicine bag is a non-woven fabric bag, and the length of the non-woven fabric bag is 15-25cm, and the width of the non-woven fabric bag is 4-6 cm.
7. The process for preparing a medicament for the treatment of ophthalmic diseases according to claim 6, which further comprises steaming the Chinese medicinal application for 20-30min, and then cooling to 40-42 ℃.
8. The Chinese medicinal composition for treating eye diseases according to claim 1, wherein the Chinese medicinal composition is a capsule prepared by adding capsule adjuvants.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010702633.2A CN111803552A (en) | 2020-07-17 | 2020-07-17 | A Chinese medicinal composition for treating eye diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010702633.2A CN111803552A (en) | 2020-07-17 | 2020-07-17 | A Chinese medicinal composition for treating eye diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111803552A true CN111803552A (en) | 2020-10-23 |
Family
ID=72865915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010702633.2A Pending CN111803552A (en) | 2020-07-17 | 2020-07-17 | A Chinese medicinal composition for treating eye diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111803552A (en) |
-
2020
- 2020-07-17 CN CN202010702633.2A patent/CN111803552A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| 王新昌: "白头翁汤治疗天行赤眼87例", 《国医论坛》 * |
| 王辉武: "《中医百家药论荟萃》", 28 February 2017, 重庆出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102362924B (en) | Medicinal composition for treating ophthalmic diseases and preparation method thereof | |
| CN106539083A (en) | It is a kind of to be used to prevent and treat diabetic retinopathy, alleviate asthenopic compositionss | |
| CN105106318A (en) | Traditional Chinese medicine composition for treating xerophthalmia and preparation method of traditional Chinese medicine composition | |
| CN107137599A (en) | A kind of anthocyanidin formula eye sticker and preparation method thereof | |
| Martyn et al. | Glial hamartoma of the retina in generalized neurofibromatosis, Von Recklinghausen's disease. | |
| CN111803552A (en) | A Chinese medicinal composition for treating eye diseases | |
| CN110327401A (en) | Treat amblyopia and the Chinese medicinal plaster of myopia and preparation method thereof | |
| CN105125630A (en) | Eye drops and preparation method thereof | |
| CN206566238U (en) | A kind of Chinese medicine nano magnetite for treating cataract myopia is smoked to treat piece glasses | |
| CN104906220A (en) | Traditional Chinese medicine for treating herpes zoster and herpes simplex viral keratitis | |
| CN108578523A (en) | Prevent the gasification infiltration fat glasses and preparation method thereof of macular degeneration cataract myopia | |
| CN104027651A (en) | Eye drops for treating eye diseases | |
| CN211095171U (en) | Eye-shade with effect of improving eyesight for myopia and presbyopia | |
| CN113197979A (en) | Eye-protecting eye-shade medicine bag | |
| CN111685934A (en) | Eye shield with plant nano crystals and function of improving eyesight and preparation method of eye shield | |
| CN101804057A (en) | Chuagxiongzine ophthalmic preparation | |
| CN109581693A (en) | A kind of plant crystal room temperature gasification glasses preventing near-sighted cataract | |
| CN209070254U (en) | A kind of plant crystal room temperature gasification glasses preventing near-sighted cataract | |
| CN117883524A (en) | Liver nourishing and eyesight improving composition and preparation method and application thereof | |
| CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof | |
| CN114588218A (en) | Traditional Chinese medicine composition for treating thyroid-associated ophthalmopathy and eye patch containing same | |
| CN105998755A (en) | Mild-moxibustion medicine and mild-moxibustion apparatus for treating myopia and amblyopia | |
| Ginsburg et al. | The effect of detergent on the penetration of sodium sulphacetamide (albucid soluble) into ocular tissues | |
| CN113398252A (en) | Eye drop rich in animal and plant active ingredients and preparation method thereof | |
| CN105641255A (en) | Eye drops capable of diminishing inflammation, inducing resuscitation and improving eyesight and preparation method of eye drops |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201023 |